In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Luis Miguel Ruilope
Speaker
Luis Miguel Ruilope
Luis Miguel Ruilope Luis Miguel Ruilope

University Hospital 12 de Octubre, Madrid (Spain)

Specialities : Hypertension , Other

26 presentations from this speaker

Hypertension in renal failure.

Event : ESC Congress 2019

  • Session : Management of high risk hypertension
  • Speaker : LM Ruilope (Madrid,ES)

A new efficient and flexible cardiovascular risk model for working population

Event : ESC Congress 2018

  • Session : Preventive cardiology
  • Speaker : LM Ruilope (Madrid,ES)

Blood pressure lowering in patients with chronic kidney disease.

Event : ESC Congress 2018

  • Session : Challenges and considerations in hypertension therapy
  • Speaker : LM Ruilope (Madrid,ES)
  • Joint with the European Society of Hypertension

Dietary habits and sick leave

Event : ESC Congress 2018

  • Session : Nutrition, malnutrition and heart disease
  • Speaker : LM Ruilope (Madrid,ES)

Positioning the topic - Current blood pressure targets

Event : ESC Congress 2017

  • Session : Blood pressure targets: is 120 too low?
  • Speaker : LM Ruilope (Madrid,ES)

Optimizing therapy for the management of resistant hypertension: time to focus on potassium?

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : LM Ruilope (Madrid,ES)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Panel discussion - Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions.

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : F Zannad (Vandoeuvre,FR), S Anker (Berlin,DE), LM Ruilope (Madrid,ES), M Kosiborod (Kansas,US)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Prevention.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines: Focus on chronic heart failure
  • Speaker : LM Ruilope (Madrid,ES)

Real world evidence: enhancing our understanding of blood pressure management.

Event : ESC Congress 2016

  • Session : Current challenges and future perspectives in hypertension
  • Speaker : LM Ruilope (Madrid,ES)
  • Sponsored by Novartis Pharma AG

Young type 2 diabetic - When to treat blood pressure and how low to go? - What do the Guidelines say?

Event : ESC Congress 2016

  • Session : Guidelines in hypertension - Dilemmas in daily practice
  • Speaker : LM Ruilope (Madrid,ES)

How big is the problem? Unmet medical needs in patients with NVAF: focus on renal impairment and elderly – Insights from the nephrologist.

Event : Heart Failure 2015

  • Session : Practical guidance on the use of oral factor Xa inhibitors in non-valvular atrial fibrillation: multidisciplinary perspectives
  • Speaker : LM Ruilope (Madrid,ES)
  • Sponsored by Bristol-Myers Squibb and Pfizer

Importance of blood pressure control in heart failure management.

Event : Heart Failure 2015

  • Session : Use of angiotensin II receptor blockers and heart failure
  • Speaker : LM Ruilope (Madrid,ES)
  • Sponsored by Takeda Pharmaceuticals

Introduction.

Event : Heart Failure 2015

  • Session : Use of angiotensin II receptor blockers and heart failure
  • Speaker : LM Ruilope (Madrid,ES)
  • Sponsored by Takeda Pharmaceuticals

Microvascular injury and the kidney in hypertension.

Event : ESC Congress 2015

  • Session : Microcirculatory damage in hypertension
  • Speaker : LM Ruilope (Madrid,ES)

White coat hypertension.

Event : ESC Congress 2015

  • Session : Challenges in hypertension
  • Speaker : LM Ruilope (Madrid,ES)

‘Talk show’ with Q&A and discussions - Hypertension care: it’s time to act.

Event : ESC Congress 2014

  • Session : Hypertension care: it’s time to act. Discuss with the experts! Part 2: 'The Q&A talk show’
  • Speaker : M Burnier (Lausanne,CH), LM Ruilope (Madrid,ES), R Schmieder (Erlangen,DE), M Volpe (Rome,IT), T Weiss (Wien,AT)
  • Sponsored by Daiichi Sankyo Europe GmbH and the Menarini Group

Increasing goal rates by optimising clinical work-up.

Event : ESC Congress 2014

  • Session : Hypertension care: it’s time to act. The experts talk! Part 1: 'The Satellite Symposium'
  • Speaker : LM Ruilope (Madrid,ES)
  • Sponsored by Daiichi Sankyo Europe GmbH and the Menarini Group

ALTITUDE: stopping for safety/futility.

Event : ESC Congress 2013

  • Session : Controversies in interpreting clinical trials
  • Speaker : LM Ruilope (Madrid,ES)

Novel approaches in the management of systolic hypertension.

Event : ESC Congress 2013

  • Session : Exploring new directions in the treatment of systolic hypertension: modulation of the natriuretic peptide system and the renin-angiotensin-aldosterone system (RAAS)
  • Speaker : LM Ruilope (Madrid,ES)
  • Sponsored by Novartis Pharma AG

Should thiazides or thiazide-like drugs be used in hypertension?

Event : ESC Congress 2013

  • Session : Time for reappraisal of diuretics?
  • Speaker : LM Ruilope (Madrid,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are